Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Shares Issued (2017 - 2025)

Assembly Biosciences has reported Shares Issued over the past 10 years, most recently at -$1.8 million for Q4 2025.

  • Quarterly results put Shares Issued at -$1.8 million for Q4 2025, down 188.52% from a year ago — trailing twelve months through Dec 2025 was $125000.0 (down 93.84% YoY), and the annual figure for FY2025 was $125000.0, down 93.84%.
  • Shares Issued for Q4 2025 was -$1.8 million at Assembly Biosciences, down from $1.9 million in the prior quarter.
  • Over the last five years, Shares Issued for ASMB hit a ceiling of $34.1 million in Q1 2021 and a floor of -$1.8 million in Q4 2025.
  • Median Shares Issued over the past 5 years was $2.0 million (2024), compared with a mean of $5.0 million.
  • Biggest five-year swings in Shares Issued: skyrocketed 77.16% in 2021 and later tumbled 188.52% in 2025.
  • Assembly Biosciences' Shares Issued stood at $2.6 million in 2021, then crashed by 87.5% to $325000.0 in 2022, then crashed by 83.38% to $54000.0 in 2023, then skyrocketed by 3659.26% to $2.0 million in 2024, then tumbled by 188.52% to -$1.8 million in 2025.
  • The last three reported values for Shares Issued were -$1.8 million (Q4 2025), $1.9 million (Q1 2025), and $2.0 million (Q4 2024) per Business Quant data.